Hi Dvar,

Thanks for sharing this. For those who haven't seen the article, patients in the UK have been told the NHS will not pay for some cancer drugs because they are not cost effective and they have been dropped from the Cancer Drugs Fund.

There are a lot of serious questions being asked of the pharmaceutical industry on whether new drug prices are always justified.

Cancer Research UK also thinks there are some serious flaws in the way the drug approval system for the NHS works in this country – you might be interested to read our blog on the subject here and our wider thoughts on the failings of this system here.

We will continue to press the government to make sure that the approval of new drugs is as quick and fair as possible. We hope this reassures you that we’re doing everything we can to make sure our research brings benefits to patients, and to ensure the price of drugs is set at a level the NHS can afford.